Short radiation course for advanced rectal cancer symptoms
Part of Cancer, Digestive system clinical trials.
This trial tests a short course of radiation therapy to relieve symptoms like bleeding, pain, or blockage in people with advanced rectal cancer that has spread and can't be removed surgically. The goal is to improve quality of life by reducing these troubling symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a confirmed diagnosis of adenocarcinoma of the rectum.
- The cancer must have spread to other parts of the body and cannot be removed with surgery.
- You must be experiencing at least one of these symptoms: bleeding, pain, urgency to pass stool, or blockage.
- You must not have had radiation therapy to the pelvic area in the past.
- You cannot be receiving chemotherapy at the same time.
- You must not have a colostomy or ileostomy (a surgically created opening in the belly to pass waste).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a shorter course of radiation combined with chemotherapy and immunotherapy to treat mid- to low rectal cancer. The goal is to potentially improve outcomes while reducing side effects.
This trial tests a short course of radiation given before chemotherapy for people with locally advanced rectal cancer (cancer that has grown into nearby tissue and/or nearby lymph nodes but can still be removed). It may help shrink the tumor and make treatment more effective while assessing how well this approach works.
This trial compares a shorter course of radiation (given over 1 week) versus the usual longer course (over 5–6 weeks) before surgery for locally advanced rectal cancer. The goal is to see if the shorter course works just as well and is more convenient.
This trial tests a shorter radiation course combined with two chemotherapy drugs and an immunotherapy drug for people with locally advanced rectal cancer that is microsatellite stable. The goal is to shrink the tumor before surgery, which may improve outcomes with fewer side effects.
This trial tests a short course of radiation therapy combined with chemotherapy for people with stage II or III rectal cancer. It’s designed to see whether this approach is safe and effective before or around cancer surgery.
This trial tests a short course of radiation with chemotherapy, targeted therapy, and immunotherapy before surgery for locally advanced rectal cancer. It aims to shrink the tumor and improve outcomes.
Hear when a new Metastatic Cancer Rectum trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.